Literature DB >> 15265338

Neurological conditions at altitude that fall outside the usual definition of altitude sickness.

Buddha Basnyat1, Tianyi Wu, Jeffrey H Gertsch.   

Abstract

Altitude sickness in its commonly recognized forms consists of acute mountain sickness and the two life-threatening forms, high altitude cerebral and pulmonary edema. Less well known are other conditions, chiefly neurological, that may arise completely outside the usual definition of altitude sickness. These, often focal, neurological conditions are important to recognize so that they do not become categorized as altitude sickness because, besides oxygen and descent, treatment may be vastly different. Transient ischemic attacks, cerebral venous thrombosis, seizures, syncope, double vision, and scotomas are some of the well-documented neurological disturbances at high altitude discussed here in order to enhance their recognition and treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15265338     DOI: 10.1089/1527029041352126

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  12 in total

1.  Effect of body position and oxygen tension on foramen ovale recruitment.

Authors:  Kayla L Moses; Arij G Beshish; Nicole Heinowski; Kim R Baker; David F Pegelow; Marlowe W Eldridge; Melissa L Bates
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-12       Impact factor: 3.619

Review 2.  Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability.

Authors:  Fenella J Kirkham; Avijit K Datta
Journal:  Dev Sci       Date:  2006-07

Review 3.  Pulmonary pathways and mechanisms regulating transpulmonary shunting into the general circulation: an update.

Authors:  Andrew T Lovering; Jonathan E Elliott; Kara M Beasley; Steven S Laurie
Journal:  Injury       Date:  2010-11       Impact factor: 2.586

4.  Prolonged high-altitude residence impacts verbal working memory: an fMRI study.

Authors:  Xiaodan Yan; Jiaxing Zhang; Qiyong Gong; Xuchu Weng
Journal:  Exp Brain Res       Date:  2010-11-25       Impact factor: 1.972

5.  Hyperbaric oxygen therapy ameliorates acute brain injury after porcine intracerebral hemorrhage at high altitude.

Authors:  Hai-tao Zhu; Chen Bian; Ji-chao Yuan; Xiao-jun Liao; Wei Liu; Gang Zhu; Hua Feng; Jiang-kai Lin
Journal:  Crit Care       Date:  2015-06-15       Impact factor: 9.097

6.  Cerebral Venous Sinus Thrombosis during Everest Expedition: A Case Report and Review of the Literature.

Authors:  P Khanal; L Thapa; A M Shrestha; S Bhattarai; D Sapkota; N Sharma; U P Devkota
Journal:  Case Rep Neurol Med       Date:  2016-10-31

7.  Caudwell Xtreme Everest: A prospective study of the effects of environmental hypoxia on cognitive functioning.

Authors:  Konstadina Griva; Jan Stygall; Mark H Wilson; Daniel Martin; Denny Levett; Kay Mitchell; Monty Mythen; Hugh E Montgomery; Mike P Grocott; Golnar Aref-Adib; Mark Edsell; Tracie Plant; Chris Imray; Debbie Cooke; Jane Harrington; Maryam Khosravi; Stanton P Newman
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

8.  Effect of Acute, Subacute, and Repeated Exposure to High Altitude (5050 m) on Psychomotor Vigilance.

Authors:  Matiram Pun; Sara E Hartmann; Michael Furian; Adrienna M Dyck; Lara Muralt; Mona Lichtblau; Patrick R Bader; Jean M Rawling; Silvia Ulrich; Konrad E Bloch; Marc J Poulin
Journal:  Front Physiol       Date:  2018-06-04       Impact factor: 4.566

9.  Cerebral Venous Thrombosis at High Altitude: A Retrospective Cohort of Twenty-one Consecutive Patients.

Authors:  Nicolas K Khattar; Fitri Sumardi; Ajmal Zemmar; Quinghua Liang; Haiyang Li; Yazhou Xing; Hugo Andrade-Barazarte; Jack L Fleming; Iype Cherian; Juha Hernesniemi; Joseph S Neimat; Robert F James; Sunil Munakomi; Dale Ding
Journal:  Cureus       Date:  2019-06-19

10.  Chronic Exposure to High Altitude: Synaptic, Astroglial and Memory Changes.

Authors:  Rupali Sharma; Nathan P Cramer; Bayley Perry; Zahra Adahman; Erin K Murphy; Xiufen Xu; Bernard J Dardzinski; Zygmunt Galdzicki; Daniel P Perl; Dara L Dickstein; Diego Iacono
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.